Huron announces intent to divest life sciences business to oliver wyman

Chicago--(business wire)--global professional services firm huron (nasdaq: hurn) today announced it has entered into a definitive agreement to divest its life sciences commercial and r&d strategy, pricing and market access strategy business (the “life sciences business”) to oliver wyman. oliver wyman is a global management consulting firm and a business of marsh mclennan (nyse: mmc). “combining oliver wyman's global focus and capabilities with huron's deep industry expertise will provide th
HURN Ratings Summary
HURN Quant Ranking